Yahoo
NYSE - Delayed Quote USD

Globus Medical, Inc. (GMED)

78.29 +0.17 (+0.22%)
At close: September 4 at 4:00:03 PM EDT
79.24 +0.95 (+1.21%)
After hours: 8:00:00 PM EDT
Trade GMED on Coinbase
Chart Range Bar
Loading chart for GMED
  • Previous Close 78.12
  • Open 77.23
  • Bid 78.50 x 30000
  • Ask 81.55 x 20000
  • Day's Range 77.07 - 78.68
  • 52 Week Range 54.15 - 101.40
  • Volume 1,123,624
  • Avg. Volume 1,586,874
  • Market Cap (intraday) 10.511B
  • Beta (5Y Monthly) 0.96
  • PE Ratio (TTM) 19.97
  • EPS (TTM) 3.92
  • Earnings Date (est.) Nov 5, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 103.23

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

www.globusmedical.com

6,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

GMED
10.33%
S&P 500 (^GSPC)
12.75%

1-Year Return

GMED
29.86%
S&P 500 (^GSPC)
18.71%

3-Year Return

GMED
44.37%
S&P 500 (^GSPC)
70.93%

5-Year Return

GMED
6.45%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 789.61M
Earnings 151.57M
Profit Margin 19.20%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
200M
400M
600M
800M
16.0%
17.0%
18.0%
19.0%

Analyst Insights

View More

Analyst Price Targets

84.00
103.23 Average
78.29 Current
125.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/7/2026
Analyst Wells Fargo
Rating Action Maintains
Rating Overweight
Price Action Lowers
Price Target 103 -> 99

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    17.02%

  • Return on Assets (ttm)

    8.74%

  • Return on Equity (ttm)

    11.81%

  • Revenue (ttm)

    3.14B

  • Net Income Avi to Common (ttm)

    535.43M

  • Diluted EPS (ttm)

    3.92

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    595.14M

  • Total Debt/Equity (mrq)

    2.35%

  • Levered Free Cash Flow (ttm)

    554.19M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: